• Kyodo News


German chemical giant Bayer AG applied for a patent in Japan on June 15, 2007, for a technique to generate induced pluripotent stem cells, or iPS cells, from human cells, according to Patent Office data.

The application was submitted around three months before a team led by Kyoto University professor Shinya Yamanaka announced the successful generation of iPS cells from human cells.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.